Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2026)

Roivant Sciences (ROIV) posted Other Non-Current Liabilities of $38.7 million for Q1 2026, up 5611.96% on a QoQ basis from $677000.0 in Q4 2025.

Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Roivant Sciences' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $38.7 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $38.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.7 million (changed N/A YoY) and the FY2026 annual result came in at $38.7 million, changed N/A from the prior year.
  • Other Non-Current Liabilities was $38.7 million for Q1 2026 at Roivant Sciences, up from $677000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $38.7 million in Q1 2026 and bottomed at $170000.0 in Q3 2025.
  • A 5-year average of $9.3 million and a median of $4.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 168.37% — and 2024, when it sank 94.3%.
  • Roivant Sciences' Other Non-Current Liabilities stood at $21.5 million in 2022, then plunged by 79.38% to $4.4 million in 2023, then plunged by 93.07% to $307000.0 in 2024, then jumped by 120.52% to $677000.0 in 2025, then jumped by 5611.96% to $38.7 million in 2026.
  • Business Quant data shows ROIV's Other Non-Current Liabilities at $38.7 million in Q1 2026, $677000.0 in Q4 2025, and $170000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Roivant Sciences 24.35 Bn 25.12 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 38.67 Mn
Dec 31, 2025 677,000.00
Sep 30, 2025 170,000.00
Jun 30, 2025 228,000.00
Dec 31, 2024 307,000.00
Sep 30, 2024 295,000.00
Jun 30, 2024 1.66 Mn
Mar 31, 2024 2.49 Mn
Dec 31, 2023 4.43 Mn
Sep 30, 2023 5.18 Mn
Jun 30, 2023 16.90 Mn
Mar 31, 2023 17.03 Mn
Dec 31, 2022 21.48 Mn
Sep 30, 2022 9.10 Mn
Jun 30, 2022 8.16 Mn
Mar 31, 2022 21.92 Mn
Dec 31, 2021 8.18 Mn
Sep 30, 2021 8.19 Mn
Jun 30, 2021 8.19 Mn
Mar 31, 2021 8.17 Mn